Are You Overtreating The Patients?

Are You Overtreating The Patients?

Mount Sinai Health System

8 months
24 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:

Michael Buckstein, MD of Mount Sinai answers commonly asked questions by his colleagues: are you overtreating the patients? What is our toxicity profile? How often do patients recur after the treatments?

______


Preliminary results from this Phase II trial show very promising response rates when combining TACE+SBRT in large, unresectable HCC with excellent OS, PFS, and CSS.  These preliminary data are currently being confirmed in an expanded cohort.

Up Next Autoplay